BridgeMD
New treatment option for Cancer
Official title Digital Art Therapy for Young Cancer Survivors
ClinicalTrials.gov ID: NCT06789666
What this study is testing
- What it's testing
- This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
- Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age 18-25 years at the time of consent.
- Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
You likely can't join if
- All people meeting any of the exclusion criteria at baseline will be excluded from study participation.
- Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much...
- people who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you...
- people unable to provide consent.
- Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.
See the full eligibility criteria
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
- Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age 18-25 years at the time of consent.
- Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
- Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
- Answers "yes" to the question "Do you experience mood issues (yes or no)?".
- All people meeting any of the exclusion criteria at baseline will be excluded from study participation.
- Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
- people who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
- people unable to provide consent.
- Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.
The study team makes the final eligibility decision.
Where it's taking place
- Chapel Hill, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.